# Clinical Profile and Complications Experienced by Chronic Kidney Disease Patients undergoing Hemodialysis in a Tertiary Hospital of Nepal: An Observational Study

**Authors:** Bimala Kumari Sah, Imran Khan, Ashesh Dhungana

PMC · DOI: 10.31729/jnma.8945 · JNMA: Journal of the Nepal Medical Association · 2025-04-30

## TL;DR

This study examines the clinical profile and complications of chronic kidney disease patients undergoing hemodialysis in Nepal, finding common issues like reduced urine output and hypertension.

## Contribution

The study provides a detailed clinical profile and identifies common complications among hemodialysis patients in a Nepalese tertiary hospital.

## Key findings

- Most patients were 50 years or younger, with a mean age of 48.76 years.
- Common complications included oliguria, weakness, and insomnia.
- Hypertension was the most frequent underlying condition, often co-occurring with diabetes.

## Abstract

Chronic kidney disease is emerging public health problems globally. Hemodialysis is the commonest treatment modality but it causes some complications and fluctuation in parameters. This study aimed to assess the clinical profile and complications experienced by chronic kidney disease patients undergoing hemodialysis.

This was an observational study conducted from December, 2023 to February, 2024 Patients aged 20 and above, receiving hemodialysis more than three months were included in the study. Descriptive analysis was done.

Among 110 CKD patients undergoing hemodialysis, 62 (56.36%) were 50 years of age or younger, with a mean 48.76±13.365. The study population included 66 (60%) male and mean age of the patients was 48.76±13.36. In this study group 90 (81.82%) had two session of dialysis per week. Mean Pre-HD systolic blood pressure was 150.64±23.95 mmHg and Post-HD was 147.64±24.38 mmHg. In this study the mean hemoglobin was 9.38±1.85 gm/dl, glucose was 110.85±46.62 mg/dl, urea 91.81±37.73 mg/dl and creatinine 7.94±2.68 mg/dl. In the patient population undergoing dialysis oliguria was observed in 106 (96.36%), weakness 98 (89.09%) and insomnia was observed in 87 (79.09%.

In this study, more than half of the patient were in the age group of less than or equal to 50 years. Common complications included reduced urine output, weakness, and insomnia. Hypertension was the most common underlying condition, often occurring with diabetes.

## Linked entities

- **Diseases:** chronic kidney disease (MONDO:0005300), diabetes (MONDO:0005015)

## Full-text entities

- **Genes:** EPO (erythropoietin) [NCBI Gene 2056] {aka DBAL, ECYT5, EP, MVCD2}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}
- **Diseases:** anorexia (MESH:D000855), CKD (MESH:D051436), vomiting (MESH:D014839), numbness (MESH:D006987), Diabetes Mellitus (MESH:D003920), mental distress (MESH:D012128), weakness (MESH:D018908), ESRD (MESH:D007676), hyperphosphatemia (MESH:D054559), hypotension (MESH:D007022), oedema (MESH:C536897), insomnia (MESH:D007319), hypoglycemia (MESH:D007003), reduced urine output (MESH:D014555), shortness of breath (MESH:D004417), CKD (MESH:D012080), sweating (MESH:D013543), oliguria (MESH:D009846), tremors (MESH:D014202), dementia (MESH:D003704), back pain (MESH:D001416), allergic reactions (MESH:D004342), Hypertension (MESH:D006973), hyperkalemia (MESH:D006947), body aches (MESH:D010146), nausea (MESH:D009325), hypocalcemia (MESH:D006996), critically ill (MESH:D016638), anemia (MESH:D000740), Complications (MESH:D008107), headache (MESH:D006261), muscle cramps (MESH:D009120)
- **Chemicals:** Ca (MESH:D002118), glucose (MESH:D005947), creatinine (MESH:D003404), urea (MESH:D014508), Na (MESH:D012964), K (MESH:D011188), P (MESH:D010758)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12831848/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12831848/full.md

## References

22 references — full list in the complete paper: https://tomesphere.com/paper/PMC12831848/full.md

---
Source: https://tomesphere.com/paper/PMC12831848